Gatehouse Bio

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets
Xconomy
Mon, 12/9/19 - 09:40 am
AstraZeneca
Gatehouse Bio
R&D
Respiratory
Cardiovascular
sRNA